Clinical Trial Update: Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating prevention of skin cancer in high-risk renal transplant patients who switched to a sirolimus-based immunosuppressive protocol; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: University Hospital of Berlin | Conditions: Renal Transplant Patients at High-risk for Skin Cancer | Phase 4 | Status: TERMINATED